Abstract
The success of using pseudouridine (Ψ) and its methylation derivative in mRNA vaccines against SARS-CoV-2 has sparked a renewed interest in this RNA modification, known as the ‘fifth nucleotide’ of RNA. In this Review, we discuss the emerging functions of pseudouridylation in gene regulation, focusing on how pseudouridine in mRNA, tRNA and ribosomal RNA (rRNA) regulates translation. We also discuss the effects of pseudouridylation on RNA secondary structure, pre-mRNA splicing, and in vitro mRNA stability. In addition to nuclear-genome-encoded RNAs, pseudouridine is also present in mitochondria-encoded rRNA, mRNA and tRNA, where it has different distributions and functions compared with their nuclear counterparts. We then discuss the therapeutic potential of programmable pseudouridylation and mRNA vaccine optimization through pseudouridylation. Lastly, we briefly describe the latest quantitative pseudouridine detection methods. We posit that pseudouridine is a highly promising modification that merits further epitranscriptomics investigation and therapeutic application.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout





Similar content being viewed by others
References
Kierzek, E. et al. The contribution of pseudouridine to stabilities and structure of RNAs. Nucleic Acids Res. 42, 3492–3501 (2014).
Li, X. Y., Ma, S. Q. & Yi, C. Q. Pseudouridine: the fifth RNA nucleotide with renewed interests. Curr. Opin. Chem. Biol. 33, 108–116 (2016).
Marchand, V. et al. HydraPsiSeq: a method for systematic and quantitative mapping of pseudouridines in RNA. Nucleic Acids Res. 48, e110 (2020).
Roundtree, I. A., Evans, M. E., Pan, T. & He, C. Dynamic RNA modifications in gene expression regulation. Cell 169, 1187–1200 (2017).
Li, X. et al. Chemical pulldown reveals dynamic pseudouridylation of the mammalian transcriptome. Nat. Chem. Biol. 11, 592–597 (2015).
Schwartz, S. et al. Transcriptome-wide mapping reveals widespread dynamic-regulated pseudouridylation of ncRNA and mRNA. Cell 159, 148–162 (2014).
Carlile, T. M. et al. Pseudouridine profiling reveals regulated mRNA pseudouridylation in yeast and human cells. Nature 515, 143-+ (2014).
Yoon, A. et al. Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita. Science 312, 902–906 (2006).
Penzo, M. et al. Human ribosomes from cells with reduced dyskerin levels are intrinsically altered in translation. FASEB J. 29, 3472–3482 (2015).
Barozzi, C. et al. Alterations of ribosomal RNA pseudouridylation in human breast cancer. Nar. Cancer 5, zcad026 (2023).
Keszthelyi, T. M. & Tory, K. The importance of pseudouridylation: human disorders related to the fifth nucleoside. Biol. Futur. 74, 3–15 (2023).
Bykhovskaya, Y., Casas, K., Mengesha, E., Inbal, A. & Fischel-Ghodsian, N. Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am. J. Hum. Genet. 74, 1303–1308 (2004).
Shaheen, R. et al. A homozygous truncating mutation in PUS3 expands the role of tRNA modification in normal cognition. Hum. Genet. 135, 707–713 (2016).
Shaheen, R. et al. PUS7 mutations impair pseudouridylation in humans and cause intellectual disability and microcephaly. Hum. Genet. 138, 231–239 (2019).
Frye, M., Jaffrey, S. R., Pan, T., Rechavi, G. & Suzuki, T. RNA modifications: what have we learned and where are we headed? Nat. Rev. Genet. 17, 365–372 (2016).
Delaunay, S. & Frye, M. RNA modifications regulating cell fate in cancer. Nat. Cell Biol. 21, 552–559 (2019).
Wang, M. K., Gao, C. C. & Yang, Y. G. Emerging roles of RNA methylation in development. Acc. Chem. Res. 56, 3417–3427 (2023).
Wiener, D. & Schwartz, S. The epitranscriptome beyond m6A. Nat. Rev. Genet. 22, 119–131 (2021).
Shi, H., Chai, P., Jia, R. & Fan, X. Novel insight into the regulatory roles of diverse RNA modifications: re-defining the bridge between transcription and translation. Mol. Cancer 19, 78 (2020).
Liu, C. et al. Absolute quantification of single-base m6A methylation in the mammalian transcriptome using GLORI. Nat. Biotechnol. 41, 355–366 (2023).
Karijolich, J., Yi, C. & Yu, Y. T. Transcriptome-wide dynamics of RNA pseudouridylation. Nat. Rev. Mol. Cell Biol. 16, 581–585 (2015).
Li, X., Xiong, X. & Yi, C. Epitranscriptome sequencing technologies: decoding RNA modifications. Nat. Methods 14, 23–31 (2016).
Karijolich, J. & Yu, Y. T. Converting nonsense codons into sense codons by targeted pseudouridylation. Nature 474, 395–398 (2011).
Song, J. et al. CRISPR-free, programmable RNA pseudouridylation to suppress premature termination codons. Mol. Cell 83, 139–155 e139 (2023).
Adachi, H. et al. Targeted pseudouridylation: an approach for suppressing nonsense mutations in disease genes. Mol. Cell 83, 637–651 e639 (2023).
Dai, Q. et al. Quantitative sequencing using BID-seq uncovers abundant pseudouridines in mammalian mRNA at base resolution. Nat. Biotechnol. 41, 344–354 (2023).
Svidritskiy, E., Madireddy, R. & Korostelev, A. A. Structural basis for translation termination on a pseudouridylated stop codon. J. Mol. Biol. 428, 2228–2236 (2016).
Eyler, D. E. et al. Pseudouridinylation of mRNA coding sequences alters translation. Proc. Natl Acad. Sci. USA 116, 23068–23074 (2019).
Luo, N. et al. Near-cognate tRNAs increase the efficiency and precision of pseudouridine-mediated readthrough of premature termination codons. Nat. Biotechnol. 43, 114–123 (2024).
Liu, J. et al. RNA codon expansion via programmable pseudouridine editing and decoding. Nature https://doi.org/10.1038/s41586-025-09165-x (2025).
Hoernes, T. P. et al. Nucleotide modifications within bacterial messenger RNAs regulate their translation and are able to rewire the genetic code. Nucleic Acids Res. 44, 852–862 (2016).
Kim, K. Q. et al. N1-methylpseudouridine found within COVID-19 mRNA vaccines produces faithful protein products. Cell Rep. 40, 111300 (2022).
Hoernes, T. P. et al. Eukaryotic translation elongation is modulated by single natural nucleotide derivatives in the coding sequences of mRNAs. Genes 10, 84 (2019).
Pederiva, C. et al. Control of protein synthesis through mRNA pseudouridylation by dyskerin. Sci. Adv. 9, eadg1805 (2023).
Monroe, J. et al. N1-Methylpseudouridine and pseudouridine modifications modulate mRNA decoding during translation. Nat. Commun. 15, 8119 (2024).
Cui, Q. et al. Targeting PUS7 suppresses tRNA pseudouridylation and glioblastoma tumorigenesis. Nat. Cancer 2, 932–949 (2021).
Vare, V. Y., Eruysal, E. R., Narendran, A., Sarachan, K. L. & Agris, P. F. Chemical and conformational diversity of modified nucleosides affects tRNA structure and function. Biomolecules 7, 29 (2017).
Alexandrov, A. et al. Rapid tRNA decay can result from lack of nonessential modifications. Mol. Cell 21, 87–96 (2006).
Kimura, S. & Waldor, M. K. The RNA degradosome promotes tRNA quality control through clearance of hypomodified tRNA. Proc. Natl Acad. Sci. USA 116, 1394–1403 (2019).
Khonsari, B. & Klassen, R. Impact of Pus1 pseudouridine synthase on specific decoding events in Saccharomyces cerevisiae. Biomolecules 10, 729 (2020).
Schultz, S. K. et al. Modifications in the T arm of tRNA globally determine tRNA maturation, function, and cellular fitness. Proc. Natl Acad. Sci. USA 121, e2401154121 (2024).
Giege, R. & Eriani, G. The tRNA identity landscape for aminoacylation and beyond. Nucleic Acids Res. 51, 1528–1570 (2023).
Levi, O. & Arava, Y. S. Pseudouridine-mediated translation control of mRNA by methionine aminoacyl tRNA synthetase. Nucleic Acids Res. 49, 432–443 (2021).
Blanchet, S. et al. Deciphering the reading of the genetic code by near-cognate tRNA. Proc. Natl Acad. Sci. USA 115, 3018–3023 (2018).
Addepalli, B. & Limbach, P. A. Pseudouridine in the anticodon of Escherichia coli tRNATyr(QPsiA) is catalyzed by the dual specificity enzyme rluF. J. Biol. Chem. 291, 22327–22337 (2016).
Tagel, M. et al. Pseudouridines of tRNA anticodon stem-loop have unexpected role in mutagenesis in Pseudomonas sp. Microorganisms 9, 25 (2020).
Lecointe, F. et al. Lack of pseudouridine 38/39 in the anticodon arm of yeast cytoplasmic tRNA decreases in vivo recoding efficiency. J. Biol. Chem. 277, 30445–30453 (2002).
Urbonavicius, J., Qian, Q., Durand, J. M., Hagervall, T. G. & Bjork, G. R. Improvement of reading frame maintenance is a common function for several tRNA modifications. EMBO J. 20, 4863–4873 (2001).
Kumar, P., Kuscu, C. & Dutta, A. Biogenesis and function of transfer RNA-related fragments (tRFs). Trends Biochem. Sci. 41, 679–689 (2016).
Guzzi, N. et al. Pseudouridylation of tRNA-derived fragments steers translational control in stem cells. Cell 173, 1204–1216 e1226 (2018).
Guzzi, N. et al. Pseudouridine-modified tRNA fragments repress aberrant protein synthesis and predict leukaemic progression in myelodysplastic syndrome. Nat. Cell Biol. 24, 299–306 (2022).
Taoka, M. et al. Landscape of the complete RNA chemical modifications in the human 80S ribosome. Nucleic Acids Res. 46, 9289–9298 (2018).
Holvec, S. et al. The structure of the human 80S ribosome at 1.9 Å resolution reveals the molecular role of chemical modifications and ions in RNA. Nat. Struct. Mol. Biol. 31, 1251–1264 (2024).
Leppik, M. et al. Loss of conserved rRNA modifications in the peptidyl transferase center leads to diminished protein synthesis and cell growth in budding yeast. Int. J. Mol. Sci. 25, 5194 (2024).
Liang, X. H., Liu, Q. & Fournier, M. J. Loss of rRNA modifications in the decoding center of the ribosome impairs translation and strongly delays pre-rRNA processing. RNA 15, 1716–1728 (2009).
Baudin-Baillieu, A. et al. Nucleotide modifications in three functionally important regions of the Saccharomyces cerevisiae ribosome affect translation accuracy. Nucleic Acids Res. 37, 7665–7677 (2009).
McMahon, M. et al. A single H/ACA small nucleolar RNA mediates tumor suppression downstream of oncogenic RAS. eLife 8, e48847 (2019).
Ero, R., Leppik, M., Reier, K., Liiv, A. & Remme, J. Ribosomal RNA modification enzymes stimulate large ribosome subunit assembly in E. coli. Nucleic Acids Res. 52, 6614–6628 (2024).
Zhao, Y., Rai, J., Yu, H. & Li, H. CryoEM structures of pseudouridine-free ribosome suggest impacts of chemical modifications on ribosome conformations. Structure 30, 983–992 e985 (2022).
Liang, X. H., Liu, Q. & Fournier, M. J. rRNA modifications in an intersubunit bridge of the ribosome strongly affect both ribosome biogenesis and activity. Mol. Cell 28, 965–977 (2007).
Jiang, J., Aduri, R., Chow, C. S. & SantaLucia, J. Jr Structure modulation of helix 69 from Escherichia coli 23S ribosomal RNA by pseudouridylations. Nucleic Acids Res. 42, 3971–3981 (2014).
Rajan, K. S. et al. Structural and mechanistic insights into the function of Leishmania ribosome lacking a single pseudouridine modification. Cell Rep. 43, 114203 (2024).
Rajan, K. S. et al. A single pseudouridine on rRNA regulates ribosome structure and function in the mammalian parasite Trypanosoma brucei. Nat. Commun. 14, 7462 (2023).
Jack, K. et al. rRNA pseudouridylation defects affect ribosomal ligand binding and translational fidelity from yeast to human cells. Mol. Cell 44, 660–666 (2011).
Ruggero, D. et al. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science 299, 259–262 (2003).
Ding, H. et al. Implications of RNA pseudouridylation for cancer biology and therapeutics: a narrative review. J. Transl. Med. 22, 906 (2024).
Zhao, Y., Rai, J. & Li, H. Regulation of translation by ribosomal RNA pseudouridylation. Sci. Adv. 9, eadg8190 (2023).
Leppik, M., Liiv, A. & Remme, J. Random pseuoduridylation in vivo reveals critical region of Escherichia coli 23S rRNA for ribosome assembly. Nucleic Acids Res. 45, 6098–6108 (2017).
Spitale, R. C. & Incarnato, D. Probing the dynamic RNA structurome and its functions. Nat. Rev. Genet. 24, 178–196 (2023).
Cao, X. A., Zhang, Y. Y., Ding, Y. L. & Wan, Y. Identification of RNA structures and their roles in RNA functions. Nat. Rev. Mol. Cell Biol. 25, 784–801 (2024).
Strobel, E. J., Yu, A. M. & Lucks, J. B. High-throughput determination of RNA structures. Nat. Rev. Genet. 19, 615–634 (2018).
Sun, L. et al. RNA structure maps across mammalian cellular compartments. Nat. Struct. Mol. Biol. 26, 322-–330 (2019).
Rubtsov, P. M. Role of pre-mRNA secondary structures in the regulation of alternative splicing. Mol. Biol. 50, 823–830 (2016).
McManus, C. J. & Graveley, B. R. RNA structure and the mechanisms of alternative splicing. Curr. Opin. Genet. Dev. 21, 373–379 (2011).
Rodell, R., Robalin, N. & Martinez, N. M. Why U matters: detection and functions of pseudouridine modifications in mRNAs. Trends Biochem. Sci. 49, 12–27 (2024).
Hudson, G. A., Bloomingdale, R. J. & Znosko, B. M. Thermodynamic contribution and nearest-neighbor parameters of pseudouridine-adenosine base pairs in oligoribonucleotides. RNA 19, 1474–1482 (2013).
Vögele, J. et al. Structural and dynamic effects of pseudouridine modifications on noncanonical interactions in RNA. RNA 29, 790–807 (2023).
Deb, I. et al. Computational and NMR studies of RNA duplexes with an internal pseudouridine-adenosine base pair. Sci. Rep. 9, 16278 (2019).
Davis, D. R. Stabilization of RNA stacking by pseudouridine. Nucleic Acids Res. 23, 5020–5026 (1995).
Meroueh, M. et al. Unique structural and stabilizing roles for the individual pseudouridine residues in the 1920 region of Escherichia coli 23S rRNA. Nucleic Acids Res. 28, 2075–2083 (2000).
Wu, G. W., Xiao, M., Yang, C. X. & Yu, Y. T. U2 snRNA is inducibly pseudouridylated at novel sites by Pus7p and snR81 RNP. EMBO J. 30, 79–89 (2011).
Rajan, K. S. et al. Pseudouridines on Trypanosoma brucei spliceosomal small nuclear RNAs and their implication for RNA and protein interactions. Nucleic Acids Res. 47, 7633–7647 (2019).
Chen, J. L., Leeder, W. M., Morais, P., Adachi, H. & Yu, Y. T. Pseudouridylation-mediated gene expression modulation. Biochem. J. 481, 1–16 (2024).
Kennedy, S. D., Bauer, W. J., Wang, W. H. & Kielkopf, C. L. Dynamic stacking of an expected branch point adenosine in duplexes containing pseudouridine-modified or unmodified U2 snRNA sites. Biochem. Bioph Res. Co. 511, 416–421 (2019).
Wu, G. et al. Pseudouridines in U2 snRNA stimulate the ATPase activity of Prp5 during spliceosome assembly. EMBO J. 35, 654–667 (2016).
Martinez, N. M. et al. Pseudouridine synthases modify human pre-mRNA co-transcriptionally and affect pre-mRNA processing. Mol. Cell 82, 645–659 e649 (2022).
Chen, C., Zhao, X., Kierzek, R. & Yu, Y. T. A flexible RNA backbone within the polypyrimidine tract is required for U2AF65 binding and pre-mRNA splicing in vivo. Mol. Cell Biol. 30, 4108–4119 (2010).
Leppek, K. et al. Combinatorial optimization of mRNA structure, stability, and translation for RNA-based therapeutics. Nat. Commun. 13, 1536 (2022).
Mauger, D. M. et al. mRNA structure regulates protein expression through changes in functional half-life. Proc. Natl Acad. Sci. USA 116, 24075–24083 (2019).
Anderson, B. R. et al. Nucleoside modifications in RNA limit activation of 2′-5′-oligoadenylate synthetase and increase resistance to cleavage by RNase L. Nucleic Acids Res. 39, 9329–9338 (2011).
Islam, M. S., Bandyra, K. J., Chao, Y. J., Vogel, J. & Luisi, B. Impact of pseudouridylation, substrate fold, and degradosome organization on the endonuclease activity of RNase E. RNA 27, 1339–1352 (2021).
Sun, H., Li, K., Liu, C. & Yi, C. Regulation and functions of non-m6A mRNA modifications. Nat. Rev. Mol. Cell Biol. 24, 714–731 (2023).
Zhang, M. et al. Quantitative profiling of pseudouridylation landscape in the human transcriptome. Nat. Chem. Biol. 19, 1185–1195 (2023).
Suzuki, T. et al. Complete chemical structures of human mitochondrial tRNAs. Nat. Commun. 11, 4269 (2020).
Antonicka, H. et al. A pseudouridine synthase module is essential for mitochondrial protein synthesis and cell viability. EMBO Rep. 18, 28–38 (2017).
Zaganelli, S. et al. The pseudouridine synthase RPUSD4 is an essential component of mitochondrial RNA granules. J. Biol. Chem. 292, 4519–4532 (2017).
Borchardt, E. K., Martinez, N. M. & Gilbert, W. V. Regulation and function of RNA pseudouridylation in human cells. Annu. Rev. Genet. 54, 309–336 (2020).
Roovers, M., Droogmans, L. & Grosjean, H. Post-transcriptional modifications of conserved nucleotides in the T-loop of tRNA: a tale of functional convergent evolution. Genes 12, 140 (2021).
Mukhopadhyay, S., Deogharia, M. & Gupta, R. Mammalian nuclear TRUB1, mitochondrial TRUB2, and cytoplasmic PUS10 produce conserved pseudouridine 55 in different sets of tRNA. RNA 27, 66–79 (2021).
Jia, Z. et al. Human TRUB1 is a highly conserved pseudouridine synthase responsible for the formation of Psi55 in mitochondrial tRNAAsn, tRNAGln, tRNAGlu and tRNAPro. Nucleic Acids Res. 50, 9368–9381 (2022).
Wang, B. et al. Mitochondrial tRNA pseudouridylation governs erythropoiesis. Blood 144, 657–671 (2024).
Safra, M., Nir, R., Farouq, D., Vainberg Slutskin, I. & Schwartz, S. TRUB1 is the predominant pseudouridine synthase acting on mammalian mRNA via a predictable and conserved code. Genome Res. 27, 393–406 (2017).
Kramer, N. J. et al. Regulators of mitonuclear balance link mitochondrial metabolism to mtDNA expression. Nat. Cell Biol. 25, 1575–1589 (2023).
Perks, K. L. et al. PTCD1 is required for 16S rRNA maturation complex stability and mitochondrial ribosome assembly. Cell Rep. 23, 127–142 (2018).
Chu, Y. J. et al. Mitochondrial tRNA pseudouridylation regulates erythropoiesis via the mTOR signaling pathway: implications for mlasa and treatment strategies. Blood 142 (Suppl. 1), 139 (2023).
Ding, Y., Gao, B. & Huang, J. Mitochondrial cardiomyopathy: the roles of mt-tRNA Mutations. J. Clin. Med. 11, 6431 (2022).
Shi, D. et al. Pseudouridine synthase 1 regulates erythropoiesis via transfer RNAs pseudouridylation and cytoplasmic translation. iScience 27, 109265 (2024).
Song, J., Zhuang, Y. & Yi, C. Programmable RNA base editing via targeted modifications. Nat. Chem. Biol. 20, 277–290 (2024).
Song, J., Luo, N., Dong, L., Peng, J. & Yi, C. RNA base editors: the emerging approach of RNA therapeutics. Wiley Interdiscip. Rev. RNA 15, e1844 (2024).
Springer, A. D. & Dowdy, S. F. GalNAc–siRNA conjugates: leading the way for delivery of RNAi therapeutics. Nucleic Acid. Ther. 28, 109–118 (2018).
Cui, H., Zhu, X., Li, S., Wang, P. & Fang, J. Liver-targeted delivery of oligonucleotides with N-acetylgalactosamine conjugation. ACS Omega 6, 16259–16265 (2021).
White, M. B. et al. A frame-shift mutation in the cystic fibrosis gene. Nature 344, 665–667 (1990).
Monaco, A. P., Bertelson, C. J., Liechti-Gallati, S., Moser, H. & Kunkel, L. M. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 2, 90–95 (1988).
Lau, M. M. & Neufeld, E. F. A frameshift mutation in a patient with Tay–Sachs disease causes premature termination and defective intracellular transport of the alpha-subunit of β-hexosaminidase. J. Biol. Chem. 264, 21376–21380 (1989).
Nir, R. et al. A systematic dissection of determinants and consequences of snoRNA-guided pseudouridylation of human mRNA. Nucleic Acids Res. 50, 4900–4916 (2022).
Pardi, N., Hogan, M. J., Porter, F. W. & Weissman, D. mRNA vaccines — a new era in vaccinology. Nat. Rev. Drug Discov. 17, 261–279 (2018).
Kariko, K., Buckstein, M., Ni, H. & Weissman, D. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23, 165–175 (2005).
Durbin, A. F., Wang, C., Marcotrigiano, J. & Gehrke, L. RNAs containing modified nucleotides fail to trigger RIG-I conformational changes for innate immune signaling. mBio 7, e00833-16 (2016).
Anderson, B. R. et al. Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation. Nucleic Acids Res. 38, 5884–5892 (2010).
Andries, O. et al. N1-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice. J. Control. Rel. 217, 337–344 (2015).
Nelson, J. et al. Impact of mRNA chemistry and manufacturing process on innate immune activation. Sci. Adv. 6, eaaz6893 (2020).
Pardi, N. et al. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature 543, 248–251 (2017).
Richner, J. M. et al. Modified mRNA vaccines protect against zika virus infection. Cell 169, 176 (2017).
Pardi, N. et al. Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses. J. Exp. Med. 215, 1571–1588 (2018).
Morais, P., Adachi, H. & Yu, Y. T. The critical contribution of pseudouridine to mRNA COVID-19 vaccines. Front. Cell Dev. Biol. 9, 789427 (2021).
Granados-Riveron, J. T. & Aquino-Jarquin, G. Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2. Biomed. Pharmacother. 142, 111953 (2021).
Mulroney, T. E. et al. N1-methylpseudouridylation of mRNA causes +1 ribosomal frameshifting. Nature 625, 189–194 (2024).
Wang, Y., Zhang, L., Xu, Z., Miao, L. & Huang, L. mRNA vaccine with antigen-specific checkpoint blockade induces an enhanced immune response against established melanoma. Mol. Ther. 26, 420–434 (2018).
Sittplangkoon, C. et al. mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model. Front. Immunol. 13, 983000 (2022).
Rubio-Casillas, A., Cowley, D., Raszek, M., Uversky, V. N. & Redwan, E. M. Review: N1-methyl-pseudouridine (m1Psi): friend or foe of cancer? Int. J. Biol. Macromol. 267, 131427 (2024).
Ramos da Silva, J. et al. Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice. Sci. Transl. Med. 15, eabn3464 (2023).
Broos, K. et al. Particle-mediated intravenous delivery of antigen mRNA results in strong antigen-specific T-cell responses despite the induction of type I interferon. Mol. Ther. Nucleic Acids 5, e326 (2016).
Rojas, L. A. et al. Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer. Nature 618, 144–150 (2023).
Lovejoy, A. F., Riordan, D. P. & Brown, P. O. Transcriptome-wide mapping of pseudouridines: pseudouridine synthases modify specific mRNAs in S. cerevisiae. PLoS ONE 9, e110799 (2014).
Kurimoto, R. et al. The tRNA pseudouridine synthase TruB1 regulates the maturation of let-7 miRNA. EMBO J. 39, e104708 (2020).
Song, J. et al. Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation. Nat. Chem. Biol. 16, 160–169 (2020).
Zaringhalam, M. & Papavasiliou, F. N. Pseudouridylation meets next-generation sequencing. Methods 107, 63–72 (2016).
Zhao, L. Y., Song, J., Liu, Y., Song, C. X. & Yi, C. Mapping the epigenetic modifications of DNA and RNA. Protein Cell 11, 792–808 (2020).
Khoddami, V. et al. Transcriptome-wide profiling of multiple RNA modifications simultaneously at single-base resolution. Proc. Natl Acad. Sci. USA 116, 6784–6789 (2019).
Fleming, A. M. et al. Structural elucidation of bisulfite adducts to pseudouridine that result in deletion signatures during reverse transcription of RNA. J. Am. Chem. Soc. 141, 16450–16460 (2019).
Zhang, M., Xiao, Y., Jiang, Z. & Yi, C. Quantifying m6A and Ψ modifications in the transcriptome via chemical-assisted approaches. Acc. Chem. Res. 56, 2980–2991 (2023).
Xu, H. et al. Absolute quantitative and base-resolution sequencing reveals comprehensive landscape of pseudouridine across the human transcriptome. Nat. Methods 21, 2024–2033 (2024).
Huang, S. et al. Interferon inducible pseudouridine modification in human mRNA by quantitative nanopore profiling. Genome Biol. 22, 330 (2021).
Tavakoli, S. et al. Semi-quantitative detection of pseudouridine modifications and type I/II hypermodifications in human mRNAs using direct long-read sequencing. Nat. Commun. 14, 334 (2023).
Begik, O. et al. Quantitative profiling of pseudouridylation dynamics in native RNAs with nanopore sequencing. Nat. Biotechnol. 39, 1278–1291 (2021).
Makhamreh, A. et al. Nanopore signal deviations from pseudouridine modifications in RNA are sequence-specific: quantification requires dedicated synthetic controls. Sci. Rep. 14, 22457 (2024).
Huang, S., Wylder, A. C. & Pan, T. Simultaneous nanopore profiling of mRNA m6A and pseudouridine reveals translation coordination. Nat. Biotechnol. 42, 1831–1835 (2024).
Lucas, M. C. et al. Quantitative analysis of tRNA abundance and modifications by nanopore RNA sequencing. Nat. Biotechnol. 42, 72–86 (2024).
Zhang, M., Zhang, X., Ma, Y. & Yi, C. New directions for Psi and m1A decoding in mRNA: deciphering the stoichiometry and function. RNA 30, 537–547 (2024).
Gilbert, W. V. Recent developments, opportunities, and challenges in the study of mRNA pseudouridylation. RNA 30, 530–536 (2024).
Liu, N. et al. Probing N6-methyladenosine RNA modification status at single nucleotide resolution in mRNA and long noncoding RNA. RNA 19, 1848–1856 (2013).
Lei, Z. & Yi, C. A radiolabeling-free, qPCR-based method for locus-specific pseudouridine detection. Angew. Chem. Int. Ed. Engl. 56, 14878–14882 (2017).
Zhang, W., Eckwahl, M. J., Zhou, K. I. & Pan, T. Sensitive and quantitative probing of pseudouridine modification in mRNA and long noncoding RNA. RNA 25, 1218–1225 (2019).
Zhao, Y. et al. Pseudouridine detection and quantification using bisulfite incorporation hindered ligation. ACS Chem. Biol. 19, 1813–1819 (2024).
Fang, X. et al. A bisulfite-assisted and ligation-based qPCR amplification technology for locus-specific pseudouridine detection at base resolution. Nucleic Acids Res. 52, e49 (2024).
Keffer-Wilkes, L. C., Veerareddygari, G. R. & Kothe, U. RNA modification enzyme TruB is a tRNA chaperone. Proc. Natl Acad. Sci. USA 113, 14306–14311 (2016).
Liu, X. M., Zhou, J., Mao, Y., Ji, Q. & Qian, S. B. Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates. Nat. Chem. Biol. 15, 865–871 (2019).
Xu, C. et al. Structural basis for selective binding of m6A RNA by the YTHDC1 YTH domain. Nat. Chem. Biol. 10, 927–929 (2014).
Li, F., Zhao, D., Wu, J. & Shi, Y. Structure of the YTH domain of human YTHDF2 in complex with an m6A mononucleotide reveals an aromatic cage for m6A recognition. Cell Res. 24, 1490–1492 (2014).
Theler, D., Dominguez, C., Blatter, M., Boudet, J. & Allain, F. H. Solution structure of the YTH domain in complex with N6-methyladenosine RNA: a reader of methylated RNA. Nucleic Acids Res. 42, 13911–13919 (2014).
Vaidyanathan, P. P., AlSadhan, I., Merriman, D. K., Al-Hashimi, H. M. & Herschlag, D. Pseudouridine and N6-methyladenosine modifications weaken PUF protein/RNA interactions. RNA 23, 611–618 (2017).
deLorimier, E. et al. Pseudouridine modification inhibits muscleblind-like 1 (MBNL1) binding to CCUG repeats and minimally structured RNA through reduced RNA flexibility. J. Biol. Chem. 292, 4350–4357 (2017).
Edupuganti, R. R. et al. N6-methyladenosine (m6A) recruits and repels proteins to regulate mRNA homeostasis. Nat. Struct. Mol. Biol. 24, 870–878 (2017).
Fu, Y., Dominissini, D., Rechavi, G. & He, C. Gene expression regulation mediated through reversible m6A RNA methylation. Nat. Rev. Genet. 15, 293–306 (2014).
Stockert, J. A., Weil, R., Yadav, K. K., Kyprianou, N. & Tewari, A. K. Pseudouridine as a novel biomarker in prostate cancer. Urol. Oncol. 39, 63–71 (2021).
Cerneckis, J., Cui, Q., He, C., Yi, C. & Shi, Y. Decoding pseudouridine: an emerging target for therapeutic development. Trends Pharmacol. Sci. 43, 522–535 (2022).
Seidel, A., Brunner, S., Seidel, P., Fritz, G. I. & Herbarth, O. Modified nucleosides: an accurate tumour marker for clinical diagnosis of cancer, early detection and therapy control. Br. J. Cancer 94, 1726–1733 (2006).
Mengel-Jorgensen, J. & Kirpekar, F. Detection of pseudouridine and other modifications in tRNA by cyanoethylation and MALDI mass spectrometry. Nucleic Acids Res. 30, e135 (2002).
Popova, A. M. & Williamson, J. R. Quantitative analysis of rRNA modifications using stable isotope labeling and mass spectrometry. J. Am. Chem. Soc. 136, 2058–2069 (2014).
Yamauchi, Y. et al. A mass spectrometry-based method for direct determination of pseudouridine in RNA. Nucleic Acids Res. 44, e59 (2016).
Acknowledgements
This work was supported by the National Natural Science Foundation of China (22425071 and 22337001 to C.Y., and 32200467 to Q.H.), the National Key R&D Program of China (2023YFC3402200 to C.Y. and 2021YFC2302400 to M.Z.), Beijing Municipal Science & Technology Commission (Z231100002723005 to C.Y.) and the Ministry of Agriculture and Rural Affairs of China (NK2022010102 to C.Y.). Q.H. was supported in part by the Postdoctoral Fellowship of Peking-Tsinghua Center for Life Sciences.
Author information
Authors and Affiliations
Contributions
The authors contributed equally to all aspects of the article.
Corresponding author
Ethics declarations
Competing interests
The authors have filed several patents for the RESTART technology.
Peer review
Peer review information
Nature Reviews Molecular Cell Biology thanks Ute Kothe, who reviewed with Sarah Schultz, Lorenzo Montanaro, who reviewed with Giulia Venturi, and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Glossary
- Ψ-based RNA editors
-
A type of RNA single-base editor that introduce pseudouridine (Ψ) modifications at specific sites, thereby altering the function of RNA molecules.
- Box H/ACA small nucleolar ribonucleoproteins
-
A complex responsible for RNA-dependent pseudouridylation, consisting of a H/ACA box small nucleolar RNA and four proteins: NHP2, NOP10, GAR1 and DKC1.
- Box H/ACA small nucleolar RNA
-
Small nucleolar RNA that contain conserved H/ACA boxes for the recognition of partner proteins, and a pseudouridylation pocket, which directs base pairing with the substrate RNA.
- Folding traps
-
A type of RNA folding problem of misfolding into inactive, often long-lived conformations, making the escape from these conformations a rate-limiting step in the folding process.
- Near-cognate tRNAs
-
Endogenous tRNAs whose anticodon forms partial base pairing with a specific codon on the mRNA, allowing the incorporation of non-canonical amino acids during translation.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Luo, N., Huang, Q., Zhang, M. et al. Functions and therapeutic applications of pseudouridylation. Nat Rev Mol Cell Biol 26, 691–705 (2025). https://doi.org/10.1038/s41580-025-00852-1
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41580-025-00852-1
This article is cited by
-
Quantitative analysis of small RNA pseudouridylation reveals interplay of PUS enzymes in tRNA anticodon stem-loop
Nature Communications (2026)
-
RNA methylation in hepatocellular carcinoma: from metabolic reprogramming and immune escape mechanisms to small molecule inhibitor development
Journal of Translational Medicine (2025)
-
CRISPR-free RNA base editing mediated PTC-readthrough restores hearing in mice with Otof nonsense mutation
Nature Communications (2025)
-
Respiratory complex I deficiency caused by a novel multi-exonic PUS1 deletion
Journal of Human Genetics (2025)


